Pfizer Ltd. — Regulatory Filings 2020

Aug 4, 2020

Limited

The Capital, 1802 / 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

August 4, 2020

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Pursuant to Regulation 30 of the Listing Regulations, we hereby inform you that a teleconference has been scheduled with Analysts on Wednesday, August 5, 2020, at 4.00 p.m to discuss the Company’s financial performance for the quarter ended June 30, 2020.

Please note that the scheduled teleconference is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company.

This schedule of the teleconference shall also be displayed on the website of the Company – www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations.

Please take the above on record

Thanking you,

Yours truly,

For Pfizer Limited

==> picture [112 x 43] intentionally omitted <==

Prajeet Nair Company Secretary

CIN: L24231MH1950PLC008311 contactus.india@pfizer.com www.pfizerindia.com